Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants (Q40792035)

23 September 2017

title

Induction of a cytotoxic T-cell response to HIV-1 proteins with short synthetic peptides and human compatible adjuvants (English)

1 reference

23 September 2017

0 references

Peter K

1

1 reference

23 September 2017

Men Y

2

1 reference

23 September 2017

Pantaleo G

3

1 reference

23 September 2017

Gander B

4

1 reference

23 September 2017

Corradin G

5

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

23 September 2017

1 reference

23 September 2017

volume

19

1 reference

23 September 2017

issue

30

1 reference

23 September 2017

page(s)

4121-4129

1 reference

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Recovery of replication-competent HIV despite prolonged suppression of plasma viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Progress in the development of an HIV-1 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Immunological adjuvants: Desirable properties and side-effects

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Induction of protective cytotoxic T cells to murine cytomegalovirus by using a nonapeptide and a human-compatible adjuvant (Montanide ISA 720).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Phase I trial in humans of an oil-based adjuvant SEPPIC MONTANIDE ISA 720.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Protection of mice from Bordetella pertussis respiratory infection using microencapsulated pertussis fimbriae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Induction of a cytotoxic T lymphocyte response by immunization with a malaria specific CTL peptide entrapped in biodegradable polymer microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Mutations that impair a posttranscriptional step in expression of HLA-A and -B antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Immunodominance of cytotoxic T lymphocyte epitopes co-injected in vivo and modulation by interleukin-12.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

MHC ligands and peptide motifs: first listing

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Identification of type-specific cytotoxic T lymphocyte responses to homologous viral proteins in laboratory workers accidentally infected with HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

MHC-linked LMP gene products specifically alter peptidase activities of the proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

The toxicology of interleukin-12: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900179-7

7 January 2021

10.1016/S0264-410X(01)00179-7

Identifiers

DOI

1 reference

23 September 2017

1 reference